OBJECTIVE: To review the surgical management of pancreatic islet-cell tumors, with attention to preoperative localization, surgical therapy, and postoperative survival. DESIGN: Consecutive case series of patients treated surgically for pancreatic islet-cell tumor. SETTING: The Johns Hopkins Hospital, a large teaching hospital in Baltimore, Md, serving both as a primary and tertiary care center. PATIENTS: Thirty-seven patients with pancreatic islet-cell tumors treated surgically between 1979 and 1990. MAIN OUTCOME MEASURES: Success of preoperative localization studies, types of operations performed, and postoperative survival. RESULTS: Preoperative computed tomography correctly localized the tumor in 20 of 34 patients (59%); angiography in 21 of 28 patients (75%), and the combination of computed tomography and angiography in 23 of 28 patients (82%). Benign islet-cell tumors were found in 19 patients, and malignant tumors in 18 patients. Twenty-four patients (65%) had functional tumors. The proportion of patients with nonfunctioning tumors increased from 0% before 1984, to 43% from 1985 to 1990. Surgical therapy was curative in 27 patients and palliative in 10. The most commonly performed operative procedures were tumor enucleation (11 patients [30%]), distal pancreatectomy (10 patients [27%]). There was no operative mortality. The actuarial survival at 40 months was 100% in patients with benign tumors and significantly lower (66%) in patients with malignant tumors. CONCLUSIONS: This experience from a single institution underscores the role of preoperative localization studies and appropriate surgical management of these rare tumors.
OBJECTIVE: To review the surgical management of pancreatic islet-cell tumors, with attention to preoperative localization, surgical therapy, and postoperative survival. DESIGN: Consecutive case series of patients treated surgically for pancreatic islet-cell tumor. SETTING: The Johns Hopkins Hospital, a large teaching hospital in Baltimore, Md, serving both as a primary and tertiary care center. PATIENTS: Thirty-seven patients with pancreatic islet-cell tumors treated surgically between 1979 and 1990. MAIN OUTCOME MEASURES: Success of preoperative localization studies, types of operations performed, and postoperative survival. RESULTS: Preoperative computed tomography correctly localized the tumor in 20 of 34 patients (59%); angiography in 21 of 28 patients (75%), and the combination of computed tomography and angiography in 23 of 28 patients (82%). Benign islet-cell tumors were found in 19 patients, and malignant tumors in 18 patients. Twenty-four patients (65%) had functional tumors. The proportion of patients with nonfunctioning tumors increased from 0% before 1984, to 43% from 1985 to 1990. Surgical therapy was curative in 27 patients and palliative in 10. The most commonly performed operative procedures were tumor enucleation (11 patients [30%]), distal pancreatectomy (10 patients [27%]). There was no operative mortality. The actuarial survival at 40 months was 100% in patients with benign tumors and significantly lower (66%) in patients with malignant tumors. CONCLUSIONS: This experience from a single institution underscores the role of preoperative localization studies and appropriate surgical management of these rare tumors.
Authors: Yassar M Hashim; Kathryn M Trinkaus; David C Linehan; Steven S Strasberg; Ryan C Fields; Dengfeng Cao; William G Hawkins Journal: Ann Surg Date: 2014-02 Impact factor: 12.969
Authors: Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm Journal: World J Surg Date: 2004-11-11 Impact factor: 3.352
Authors: Timothy L Fitzgerald; Andrew J Smith; Max Ryan; Mostafa Atri; Frances C Wright; Calvin H L Law; Sherif S Hanna Journal: Can J Surg Date: 2003-12 Impact factor: 2.089
Authors: A Dhar; Y Chawla; R K Dhiman; S Suri; A Behera; A Bhansali; R Sud; R Katariya; J Dilawari Journal: Dig Dis Sci Date: 1995-11 Impact factor: 3.199
Authors: Susan C Pitt; Henry A Pitt; Marshall S Baker; Kathleen Christians; John G Touzios; James M Kiely; Sharon M Weber; Stuart D Wilson; Thomas J Howard; Mark S Talamonti; Layton F Rikkers Journal: J Gastrointest Surg Date: 2009-06-23 Impact factor: 3.452